Disease-modifying treatments for early and advanced multiple sclerosis: a new treatment paradigm von Giovannoni, Gavin

Volltext

Quality of life should be the primary outcome for disease-modifying therapy trials in MS: Commentary von Giovannoni, Gavin

Volltext

Systematic review and meta-analysis of the association between Epstein–Barr virus, multiple sclerosis and other risk factors von Jacobs, Benjamin M, Giovannoni, Gavin, Cuzick, Jack, Dobson, Ruth

Volltext

Placebo-Controlled Phase 3 Study of Oral BG-12 for Relapsing Multiple Sclerosis von Gold, Ralf, Kappos, Ludwig, Arnold, Douglas L, Bar-Or, Amit, Giovannoni, Gavin, Selmaj, Krzysztof, Tornatore, Carlo, Sweetser, Marianne T, Yang, Minhua, Sheikh, Sarah I, Dawson, Katherine T

Volltext

Contribution of Relapse-Independent Progression vs Relapse-Associated Worsening to Overall Confirmed Disability Accumulation in Typical Relapsing Multiple Sclerosis in a Pooled Ana... von Kappos, Ludwig, Wolinsky, Jerry S, Giovannoni, Gavin, Arnold, Douglas L, Wang, Qing, Bernasconi, Corrado, Model, Fabian, Koendgen, Harold, Manfrini, Marianna, Belachew, Shibeshih, Hauser, Stephen L

Volltext

Multiple sclerosis: risk factors, prodromes, and potential causal pathways von Ramagopalan, Sreeram V, DPhil, Dobson, Ruth, MRCP, Meier, Ute C, DPhil, Giovannoni, Gavin, Prof

Volltext

Cognition and its relation to brain health in patients with MS: Response to letter von Hobart, Jeremy, Giovannoni, Gavin

Volltext

Safety and efficacy of cladribine tablets in patients with relapsing–remitting multiple sclerosis: Results from the randomized extension trial of the CLARITY study von Giovannoni, Gavin, Soelberg Sorensen, Per, Cook, Stuart, Rammohan, Kottil, Rieckmann, Peter, Comi, Giancarlo, Dangond, Fernando, Adeniji, Abidemi K, Vermersch, Patrick

Volltext

Ocrelizumab versus Interferon Beta-1a in Relapsing Multiple Sclerosis von Hauser, Stephen L, Bar-Or, Amit, Comi, Giancarlo, Giovannoni, Gavin, Hartung, Hans-Peter, Hemmer, Bernhard, Lublin, Fred, Montalban, Xavier, Rammohan, Kottil W, Selmaj, Krzysztof, Traboulsee, Anthony, Wolinsky, Jerry S, Arnold, Douglas L, Klingelschmitt, Gaelle, Masterman, Donna, Fontoura, Paulo, Belachew, Shibeshih, Chin, Peter, Mairon, Nicole, Garren, Hideki, Kappos, Ludwig

Volltext

Ocrelizumab versus Placebo in Primary Progressive Multiple Sclerosis von Montalban, Xavier, Hauser, Stephen L, Kappos, Ludwig, Arnold, Douglas L, Bar-Or, Amit, Comi, Giancarlo, de Seze, Jérôme, Giovannoni, Gavin, Hartung, Hans-Peter, Hemmer, Bernhard, Lublin, Fred, Rammohan, Kottil W, Selmaj, Krzysztof, Traboulsee, Anthony, Sauter, Annette, Masterman, Donna, Fontoura, Paulo, Belachew, Shibeshih, Garren, Hideki, Mairon, Nicole, Chin, Peter, Wolinsky, Jerry S

Volltext

Epstein–Barr Virus in Multiple Sclerosis: Theory and Emerging Immunotherapies von Bar-Or, Amit, Pender, Michael P., Khanna, Rajiv, Steinman, Lawrence, Hartung, Hans-Peter, Maniar, Tap, Croze, Ed, Aftab, Blake T., Giovannoni, Gavin, Joshi, Manher A.

Volltext

The COVID-19 pandemic and the use of MS disease-modifying therapies von Giovannoni, Gavin, Hawkes, Chris, Lechner-Scott, Jeannette, Levy, Michael, Waubant, Emmanuelle, Gold, Julian

Volltext

Epidemiology of Epstein-Barr virus infection and infectious mononucleosis in the United Kingdom von Kuri, Ashvin, Jacobs, Benjamin Meir, Vickaryous, Nikki, Pakpoor, Julia, Middeldorp, Jaap, Giovannoni, Gavin, Dobson, Ruth

Volltext

Trial of Fingolimod versus Interferon Beta-1a in Pediatric Multiple Sclerosis von Chitnis, Tanuja, Arnold, Douglas L, Banwell, Brenda, Brück, Wolfgang, Ghezzi, Angelo, Giovannoni, Gavin, Greenberg, Benjamin, Krupp, Lauren, Rostásy, Kevin, Tardieu, Marc, Waubant, Emmanuelle, Wolinsky, Jerry S, Bar-Or, Amit, Stites, Tracy, Chen, Yu, Putzki, Norman, Merschhemke, Martin, Gärtner, Jutta

Volltext

Durability of no evidence of disease activity-3 (NEDA-3) in patients receiving cladribine tablets: The CLARITY extension study von Giovannoni, Gavin, Singer, Barry A, Issard, Delphine, Jack, Dominic, Vermersch, Patrick

Volltext

The Multiple Sclerosis Care Unit von Soelberg Sorensen, Per, Giovannoni, Gavin, Montalban, Xavier, Thalheim, Christoph, Zaratin, Paola, Comi, Giancarlo

Volltext

Meta-analysis of early nonmotor features and risk factors for Parkinson disease von Noyce, Alastair J., Bestwick, Jonathan P., Silveira-Moriyama, Laura, Hawkes, Christopher H., Giovannoni, Gavin, Lees, Andrew J., Schrag, Anette

Volltext

Cladribine to Treat Relapsing Forms of Multiple Sclerosis von Giovannoni, Gavin

Volltext

Effects of cladribine tablets on lymphocyte subsets in patients with multiple sclerosis: an extended analysis of surface markers von Stuve, Olaf, Soelberg Soerensen, Per, Leist, Thomas, Giovannoni, Gavin, Hyvert, Yann, Damian, Doris, Dangond, Fernando, Boschert, Ursula

Volltext

Smouldering multiple sclerosis: the ‘real MS’ von Giovannoni, Gavin, Popescu, Veronica, Wuerfel, Jens, Hellwig, Kerstin, Iacobaeus, Ellen, Jensen, Michael B., García-Domínguez, José Manuel, Sousa, Livia, De Rossi, Nicola, Hupperts, Raymond, Fenu, Giuseppe, Bodini, Benedetta, Kuusisto, Hanna-Maija, Stankoff, Bruno, Lycke, Jan, Airas, Laura, Granziera, Cristina, Scalfari, Antonio

Volltext